[Shock-treatment in gastro-intestinal-bleeding with 3,5% isocyanate crosslinked polypeptide solution].
In a prospective study infusions of 3,5% isocyanate crosslinked polypeptide solution 500 ml (Haemaccel 3,5%) were given to patients with gastro-intestinal-bleeding for shock treatment and prophylaxis. The increase in intravascular volume was always satisfactory. We did not see any undesirable side effects (anaphylaxis, anaphylactoid reaction, coagulopathy, oliguria).
D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D010952:Plasma Substitutes / Q000009:adverse effects / Q000627:therapeutic use*; D011097:Polygeline / Q000009:adverse effects / Q000627:therapeutic use*; D011108:Polymers / Q000627:therapeutic use*; D011446:Prospective Studies; D012771:Shock, Hemorrhagic / Q000188:drug therapy*
D010952:Plasma Substitutes; D011108:Polymers; D011097:Polygeline
Schockbekämpfung bei Blutungen aus dem oberen Gastrointestinaltrakt mit 3,5% isozyanatvernetzter Gelatine.